Exercise Intolerance Is Associated with Cardiovascular Dysfunction in Long COVID-19 Syndrome, 2024, Vontetsianos et al

Discussion in 'Long Covid research' started by SNT Gatchaman, Jul 28, 2024.

  1. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    5,451
    Location:
    Aotearoa New Zealand
    Exercise Intolerance Is Associated with Cardiovascular Dysfunction in Long COVID-19 Syndrome
    Vontetsianos, Angelos; Chynkiamis, Nikolaos; Gounaridi, Maria Ioanna; Anagnostopoulou, Christina; Lekka, Christiana; Zaneli, Stavroula; Anagnostopoulos, Nektarios; Oikonomou, Evangelos; Vavuranakis, Manolis; Rovina, Nikoletta; Papaioannou, Andriana I.; Kaltsakas, Georgios; Koulouris, Nikolaos; Vogiatzis, Ioannis

    BACKGROUND/OBJECTIVES
    Cardiorespiratory complications are commonly reported among patients with long COVID-19 syndrome. However, their effects on exercise capacity remain inconclusive. We investigated the impact of long COVID-19 on exercise tolerance combining cardiopulmonary exercise testing (CPET) with resting echocardiographic data.

    METHODS
    Forty-two patients (55 ± 13 years), 149 ± 92 days post-hospital discharge, and ten healthy age-matched participants underwent resting echocardiography and an incremental CPET to the limit of tolerance. Left ventricular global longitudinal strain (LV-GLS) and the left ventricular ejection fraction (LVEF) were calculated to assess left ventricular systolic function. The E/e’ ratio was estimated as a surrogate of left ventricular end-diastolic filling pressures. Tricuspid annular systolic velocity (SRV) was used to assess right ventricular systolic performance. Through tricuspid regurgitation velocity and inferior vena cava diameter, end-respiratory variations in systolic pulmonary artery pressure (PASP) were estimated. Peak work rate (WRpeak) and peak oxygen uptake (VO2peak) were measured via a ramp incremental symptom-limited CPET.

    RESULTS
    Compared to healthy participants, patients had a significantly (p < 0.05) lower LVEF (59 ± 4% versus 49 ± 5%) and greater left ventricular end-diastolic diameter (48 ± 2 versus 54 ± 5 cm). In patients, there was a significant association of E/e’ with WRpeak (r = −0.325) and VO2peak (r = −0.341). SRV was significantly associated with WRpeak (r = 0.432) and VO2peak (r = 0.556). LV-GLS and PASP were significantly correlated with VO2peak (r = −0.358 and r = −0.345, respectively).

    CONCLUSIONS
    In patients with long COVID-19 syndrome, exercise intolerance is associated with left ventricular diastolic performance, left ventricular end-diastolic pressure, PASP and SRV. These findings highlight the interrelationship of exercise intolerance with left and right ventricular performance in long COVID-19 syndrome.

    Link | PDF (Journal of Clinical Medicine) [Open Access]
     

Share This Page